Client Result
Rivian IPO Underwriters Secure Appellate Victory in Securities Class Action
1 minute read | April.25.2025

1 minute read | April.25.2025
1 minute read | May.06.2024
Meta prevails in important test of corporate law protections, earning Orrick recognition in Litigators of the Week.
June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
September.29.2021